Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study.

Hompe ED, Jacobson DL, Eudailey JA, Butler K, Edwards W, Pollara J, Brummel SS, Fouda GG, Chinula L, Kamanga M, Kinikar A, Moodley D, Owor M, Fowler MG, Permar SR.

mSphere. 2019 Oct 23;4(5). pii: e00716-19. doi: 10.1128/mSphere.00716-19.

2.

Observed controls on resilience of groundwater to climate variability in sub-Saharan Africa.

Cuthbert MO, Taylor RG, Favreau G, Todd MC, Shamsudduha M, Villholth KG, MacDonald AM, Scanlon BR, Kotchoni DOV, Vouillamoz JM, Lawson FMA, Adjomayi PA, Kashaigili J, Seddon D, Sorensen JPR, Ebrahim GY, Owor M, Nyenje PM, Nazoumou Y, Goni I, Ousmane BI, Sibanda T, Ascott MJ, Macdonald DMJ, Agyekum W, Koussoubé Y, Wanke H, Kim H, Wada Y, Lo MH, Oki T, Kukuric N.

Nature. 2019 Aug;572(7768):230-234. doi: 10.1038/s41586-019-1441-7. Epub 2019 Aug 7.

PMID:
31391559
3.

Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.

Sebikari D, Farhad M, Fenton T, Owor M, Stringer JSA, Qin M, Chakhtoura N, Chi BH, Saidi F, Nevrekar N, Violari A, Chipato T, McIntyre JA, Moodley D, Taha TE, Theron G, Fowler MG.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):521-532. doi: 10.1097/QAI.0000000000002072.

PMID:
31295174
4.

Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women.

Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M.

AIDS. 2019 Aug 1;33(10):1657-1662. doi: 10.1097/QAD.0000000000002237.

PMID:
31021852
5.

21st century research in urban WASH and health in sub-Saharan Africa: methods and outcomes in transition.

Mackinnon E, Ayah R, Taylor R, Owor M, Ssempebwa J, Olago LD, Kubalako R, Dia AT, Gaye C, C Campos L, Fottrell E.

Int J Environ Health Res. 2019 Aug;29(4):457-478. doi: 10.1080/09603123.2018.1550193. Epub 2018 Dec 13. Review.

PMID:
30545246
6.

Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.

Flynn PM, Taha TE, Cababasay M, Fowler MG, Mofenson LM, Owor M, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanashanmugam D, Chakhtoura N, McCarthy K, Mukuzunga C, Makanani B, Moodley D, Nematadzira T, Kusakara B, Patil S, Vhembo T, Bobat R, Mmbaga BT, Masenya M, Nyati M, Theron G, Mulenga H, Butler K, Shapiro DE; PROMISE Study Team.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):383-392. doi: 10.1097/QAI.0000000000001612.

7.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team.

N Engl J Med. 2016 Nov 3;375(18):1726-1737.

8.

Factors associated with adoption of beneficial newborn care practices in rural Eastern Uganda: a cross-sectional study.

Owor MO, Matovu JKB, Murokora D, Wanyenze RK, Waiswa P.

BMC Pregnancy Childbirth. 2016 Apr 21;16:83. doi: 10.1186/s12884-016-0874-3.

9.

Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival.

Owor M, Mwatha A, Donnell D, Musoke P, Mmiro F, Allen M, Jackson JB, Fowler MG, Guay LA.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):464-71. doi: 10.1097/QAI.0000000000000015.

10.

Perinatal HIV and its prevention: progress toward an HIV-free generation.

Fowler MG, Gable AR, Lampe MA, Etima M, Owor M.

Clin Perinatol. 2010 Dec;37(4):699-719, vii. doi: 10.1016/j.clp.2010.09.002. Review.

PMID:
21078445
11.

Monitoring HIV treatment in resource-limited settings: reassuring news on the usefulness of CD4(+) cell counts.

Fowler MG, Owor M.

J Infect Dis. 2009 May 1;199(9):1255-7. doi: 10.1086/597618. No abstract available.

PMID:
19317627
12.

Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.

Musoke PM, Young AM, Owor MA, Lubega IR, Brown ER, Mmiro FA, Mofenson LM, Jackson JB, Fowler MG, Guay LA.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):171-8. doi: 10.1097/QAI.0b013e318183a92a.

13.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.

Lancet. 2003 Sep 13;362(9387):859-68.

PMID:
13678973
14.

Socio-economic risk factors for severe protein energy malnutrition among children in Mulago Hospital, Kampala.

Owor M, Tumwine JK, Kikafunda JK.

East Afr Med J. 2000 Sep;77(9):471-5.

PMID:
12862136

Supplemental Content

Support Center